Oregon Health and Science University
- Image
OREGON HEALTH & SCIENCE UNIVERSITY
Our mission is to enhance the efficiency and quality of rigorously translating research ideas into impact. 
-Oregon Health and Science UniversityThe CTSA Visiting Scholar program consists of giving the virtual CTSA Grand Rounds lecture, which is open to the entire CTSA Consortium, and virtual meetings between KL2 Scholars and faculty at the host institution and their KL2 peers. There are two main goals of this program. The first is to offer the opportunity to serve as a visiting professor and help make connections with faculty that will-
-Oregon Health and Science UniversityThe CTSA Visiting Scholar program consists of giving the virtual CTSA Grand Rounds lecture, which is open to the entire CTSA Consortium, and virtual meetings between KL2 Scholars and faculty at the host institution and their KL2 peers. There are two main goals of this program. The first is to offer the opportunity to serve as a visiting professor and help make connections with faculty that will
-
-Oregon Health and Science University
The CTSA Visiting Scholar program consists of giving the virtual CTSA Grand Rounds lecture, which is open to the entire CTSA Consortium, and virtual meetings between KL2 Scholars and faculty at the host institution and their KL2 peers. There are two main goals of this program. The first is to offer the opportunity to serve as a visiting professor and help make connections with faculty that will
- Oregon Health and Science University
What does business have to do with translation? According to Balas and Boren, the gap between discovery and clinical practice, is on average, 17 years! A variety of factors contribute to this gap, but a general lack of support beyond funding is significant and persistent. CTSAs have looked to novel methods to provide this support including commercialization-focused programs for investigators
September 27, 2021OHSU startup, Inherent Targeting, is among the Pacific Northwest-based startups selected to present at the Pacific Northwest Startup Showcase & Social on Tuesday, October 12 from 10am-12pm. Inherent Targeting improves surgical outcomes with high contrast, nerve-specific fluorescent dyes that help surgeons visualize buried nerves and distinguish them from surrounding tissue. This reduces patient
September 02, 2021In 2020, the Oregon Clinical & Translational Research Institute (OCTRI) awarded Jessica Grant, an OHSU speech therapist, and David Sheridan, MD, an OCTRI Scholar and OHSU associate professor of emergency medicine, a Biomedical Innovation Program award for their device called the Koala Kushion. This week, the duo was interviewed for OHSU's Innovator Spotlight series. Read more about their progress
July 26, 2021In collaboration with the Technology Transfer and Collaborations & Entrepreneurship offices at Oregon Health & Science University (OHSU), the Oregon Clinical and Translational Research Institute (OCTRI) announced three new funded projects for the 2021 drug discovery track of the Biomedical Innovation Program. This program supports drug discovery platforms and early-stage therapeutic technology-
Oregon Health and Science UniversityCase report Forms (CRFs) are standardized documents in which the study team records data collected in a clinical trial. CRFs should support compliant collection and documentation of research data by following Good Clinical Practice and Good Documentation guidelines. This seminar will cover definitions, operational considerations, and data requirements, while focusing on data outputs (data analysis
Oregon Health and Science UniversityThis class will cover the most common questions regarding survey design and administration - and provide the answers! Topics we will cover include: Writing great survey questions Choosing previously validated questions Selecting survey software and administration methods Maximizing response rates Budgeting for your survey Designing your survey to facilitate data analysis Piloting your survey. We-
Oregon Health and Science UniversitySubject Injuries are adverse experiences that arise directly from or contributed to by the study drug(s), study device(s), or study procedures that would not have been expected from the standard treatment for the patient's condition, progression of condition, or other reasons. This training introduces the topics of subject injuries, ethical positions, informed consent language, and clinical
-Oregon Health and Science UniversityThis meeting is organized and hosted by the Genomic Data Science Working Group of the National Human Genome Research Institute (NHGRI). The primary purpose of the workshop is to stimulate discussion around the opportunities and obstacles underlying the application of machine learning (ML) methods to basic genome sciences and genomic medicine, to define the key scientific topic areas in genomics
March 08, 2021OCTRI Scholar Dr. David Sheridan (left) and Dr. Matthew Hansen (right), both OHSU Emergency Medicine physicians, were awarded OCTRI Biomedical Innovation Program (BIP) funding and project support in 2018 to develop a new bedside technology for quickly detecting sepsis using an accurate and objective measure of capillary refill time (CRT). In the last 3 years, Drs. Sheridan and Hansen leveraged
January 25, 2021A team of researchers led by Dr. Dora M. Raymaker, one of few openly autistic researchers, used a community-based participatory research (CBPR) approach to conduct an inaugural study on autistic burnout. Findings draw attention to the syndrome, long recognized by autistic people but not formally investigated, and will inform future research, prevention strategies, and interventions. Autistic
December 22, 2020In collaboration with the Technology Transfer and Collaborations & Entrepreneurship offices at Oregon Health & Science University (OHSU), the Oregon Clinical and Translational Research Institute (OCTRI) announced four new funded projects for the 2021 device and diagnostics track of the Biomedical Innovation Program. This program cultivates, evaluates, and funds promising translational projects
Urea cycle disorders (UCDs) are rare but devastating genetic conditions. In 2003, the Urea Cycle Disorders Consortium (UCDC) became one of the first members of the RDCRN. Since then, UCDC has flourished into an international network of 16 academic centers in the United States, Canada and Europe that provide state-of-the-art care and conduct cutting-edge clinical research. The UCDC is currently
The Phenylalanine Families and Researchers Exploring Evidence (PHEFREE) Consortium studies the health, neurologic, cognitive, neuropsychiatric, patient-reported and quality-of-life outcomes in individuals with chronic elevations of the amino acid phenylalanine in blood (hyperphenylalaninemia). In the United States, elevated blood phenylalanine is typically detected at birth through newborn
Virginia Commonwealth UniversityUniversity of Nebraska Medical CenterUniversity Of WashingtonUniversity Of Alabama At BirminghamUniversity Of North Carolina Chapel HillJohns Hopkins UniversityMayo ClinicOregon Health and Science UniversityMany clinical questions have arisen with the COVID-19 pandemic, from who is at greatest risk for COVID-19 infection to adverse outcomes if infected to how COVID-19 has impacted healthcare utilization patterns. To help answer these questions, and many more, the National COVID Cohort Collaborative (N3C) has integrated real-world clinical observations from across the nation into a harmonized database
Brittle bone disorders (BBDs), also known as osteogenesis imperfecta, include 13 inherited conditions involving bones that break easily. Brittle bone disorders can cause deformity and chronic pain and lead to premature death. The Brittle Bone Disorders Consortium (BBDC) includes ten medical research sites working to better understand and treat these disorders. The consortium aims to explore the
Oregon Health and Science UniversityWhen the COVID-19 pandemic hit in early 2020, traditional, in-person methods of community outreach and engagement (CE) had to be reimagined and redefined in order to accommodate new COVID-19 life-style and community needs. Through CE, the Oregon Clinical and Translational Research Institute (OCTRI) Community Research Hub works to connect and support researchers and community organizations (CBOs)
September 23, 2020The Tillamook County Wellness (TCW) coalition, of which the Oregon CTSA (OCTRI) is a member and key supporter, scored a big win recently when Tillamook Adventist Health’s newly-created Community Well-Being Division absorbed TCW’s Wellness Coordinator position – as well as the person filling it – to head Adventist’s new Division. This move was an important step, because it confirms the importance
-
-Oregon Health and Science University
OHSU is joining forces with MIT Hacking Medicine and academic and industry partners from across the Pacific Northwest to bring you the inaugural OHSU Invent-a-thon, a virtual health hackathon, October 23–25, 2020. MIT Hacking Medicine events have directly led to the creation of numerous successful companies, gaining over $250 million in funding, and even a billion-dollar acquisition. The ideas
August 07, 2020The Oregon Clinical & Translational Clinical Research Institute (OCTRI) at Oregon Health & Science University (OHSU) funded three projects for their 2020 Biomedical Innovation Program drug discovery track. The funded research covers pancreatic cancer, prostate cancer, and SARS-CoV-2. This category of funding supports drug discovery platforms and early-stage therapeutic technology projects
The Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) is a clinical trials network funded by the National Institute for Neurological Disorders and Stroke (NINDS), the National Heart Lung and Blood Institute (NHLBI) and the National Center for Advancing Translational Science (NCATS). The goal of the SIREN Network is to improve the outcomes of patients with neurologic, cardiac
Oregon Health and Science UniversityThe Oregon Clinical & Translational Research Institute (OCTRI) Recruitment team pivoted its efforts early on during the COVID pandemic in order to support clinical and translational scientists in navigating the research shutdown (and now the restart of research) at Oregon Health and Science University (OHSU).
June 18, 2020OCTRI announces six awardees to two tracks of the Biomedical Innovation Program: COVID-19 Rapid Response and Digital Health.
-
April 26, 2020Two Emergency Medicine faculty researchers at Oregon Health and Science University are looking for healthcare workers to take their research survey on the impact of COVID-19 on the healthcare workforce. This is a CTSA-supported study. See below. Are you a healthcare worker that comes in contact with patients? Concerned about COVID-19’s impact on the healthcare workforce? Participate in an
April 13, 2020The Oregon Clinical & Translational Research Institute (OCTRI) at Oregon Health & Science Universtiy (OHSU) pivoted rapidly to support our home institution and our state during this crisis. Our rapid response allowed us to become the central organizing and triage hub for clinical research during this time. This provided us the opportunity to demonstrate our value to OHSU and also to utilize the
February 12, 2020The Center for Evidence-based Policy at Oregon Health & Science University (OHSU) recently launched CLOUD: Curated Library about Opioid Use for Decision-makers. CLOUD is a user-friendly, online repository of evidence-based, actionable materials on opioids and the opioid crisis. The opioid library has three specific audiences in mind: payers & providers, policymakers & community leaders, and
Oregon Health and Science UniversityThis video provides a brief overview of sampling constructs in qualitative research.
